Acyclovir
General
- Type: Antiviral: nucleoside analoge
- Dosage Forms: IV, PO (200 mg, 400 mg, and 800 mg)
- Common Trade Names: Zovirax
Adult Dosing
Indications by Disease
| Disease | Dose | Context |
|---|---|---|
| Bell's palsy | 400mg 5x per day x1 week | Antiviral |
| Encephalitis | 10mg/kg (10-15mg/kg for pediatrics) every 8hrs | HSV |
| Herpes Simplex Virus-2 | 400mg PO q8hrs x 7-10 days or 200mg PO 5x/day x 7-10 days | Initial Episode |
| Herpes Simplex Virus-2 | 400mg PO q8hrs x 5 days or 800mg PO q12hrs x 5 days or 800mg PO q8hrs x 2 days | Recurrence |
| Herpes Simplex Virus-2 | 400mg PO q12hrs daily | Suppressive |
| Herpes gingivostomatitis | 400 mg PO 5x/day (q4hrs while awake) x 5 days | Normal host |
| Herpes gingivostomatitis | 5 mg/kg IV q8h x 7 days | Immunocompromised |
| Herpes gingivostomatitis | 400mg PO 5x/day x 14-21 days | Immunocompromised (oral) |
| Herpes labialis | 400 mg PO 5x/day (q4hrs while awake) x 5 days | Normal host |
| Herpes labialis | 5 mg/kg IV q8h x 7 days | Immunocompromised |
| Herpes labialis | 400mg PO 5x/day x 14-21 days | Immunocompromised (oral) |
Pediatric Dosing
Indications by Disease
| Disease | Dose | Context |
|---|---|---|
| Encephalitis | 20mg/kg IV q8hrs x 21 days (neonates); 10-15mg/kg IV q8hrs x 14-21 days (children) | Pediatric HSV |
| Herpes gingivostomatitis | 40-80mg/kg PO divided in 3-4 doses for 5-7 days | Normal host |
| Herpes labialis | 40-80mg/kg PO divided in 3-4 doses for 5-7 days | Normal host |
| Neonatal conjunctivitis | 20mg/kg IV q8h x 14-21 days | Herpetic conjunctivitis |
| Pediatric fever of uncertain source | 20mg/kg/dose | Neonatal 0-28 days if HSV suspected |
Special Populations
- Pregnancy Rating: B
- Lactation Risk Categories: Safe
- Renal Dosing
- Adult
- IV
- CrCl 25-50 give q12h
- CrCl 10-24 give q24h
- CrCl <10 decrease dose 50%, give q24h
- HD give usual dose as supplement
- PD no supplement
- PO
- CrCl <25: see package insert
- HD: give usual dose as supplement
- PD: no supplement
- IV
- Pediatric
- Geriatric
- Refer to adult dosing. Oral: Initial doses should begin at the low end of the dosage range
- Adult
- Hepatic Dosing
- Not defined
Contraindications
- Allergy to class/drug
Adverse Reactions
Serious
- Hallucinations / psychosis
- Seizure
- Coma
- Encephalopathy
- Thrombocytopenia
- Leukopenia
- Anaphylaxis
- Angioedema
- Erythema Multiforme
- SJS / TEN
- TTP
- Hepatitis
- Renal failure
Common
- Nausea/vomiting/diarrhea
- Headache
- Dizziness
- Rash
- Arthralgia
- Confusion / lethargy
- Elev. BUN/creatinine
- Photosensitivity
Pharmacology
- Half-life: 2.5 - 3.3 hrs
- Metabolism: virally infected cells (intracellularly); liver
- Excretion: Urine
- Mechanism of Action: Inhibits DNA polymerase
See Also
References
- Epocrates 2015
- Acetazolamide injection [prescribing information]. Big Flats, NY: X-Gen Pharmaceuticals, Inc; October 2015.
- Acetazolamide tablets [prescribing information]. Hawthorne, NY: Taro Pharmaceuticals; September 2013.
